Charge transfer-oxy radical mechanism for anticancer agents: mAMSA derivatives, rhodamine 123, and nickel

P W Crawford1, P Lumme, H Elo

  • 1Department of Chemistry, University of Wisconsin-Milwaukee 53201.

Insights

Many anticancer drugs work by creating toxic oxy radicals through redox reactions, destroying cancer cells. This study used cyclic voltammetry to analyze iminium ions, quinone derivatives, and metal complexes, linking electrochemical data to their anticancer activity.

Area of Science:

  • Biochemistry
  • Electrochemistry
  • Pharmacology

Background:

  • Anticancer agents are proposed to function via redox reactions.
  • These reactions generate toxic oxy radicals that destroy neoplastic cells.

Purpose of the Study:

  • To investigate the electrochemical properties of anticancer agents.
  • To correlate electrochemical data with physiological activity.

Main Methods:

  • Cyclic voltammetry was employed to study iminium ions (protonated mAMSA derivatives), quinone derivatives (rhodamine 123), and metal complexes (nickel(II) salicylaldoximate).
  • Literature data on relevant compounds were also included.

Main Results:

  • Electrochemical data were obtained for the selected anticancer agent classes.
  • A rationale was developed to link electrochemical behavior to biological function.

Conclusions:

  • Redox reactions and oxy radical generation are a plausible mechanism for anticancer activity.
  • Electrochemical analysis provides insights into the mechanism of action for these agents.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...